Critical Insights From Tandem Diabetes Care Analyst Ratings: What You Need To Know
Critical Insights From Tandem Diabetes Care Analyst Ratings: What You Need To Know
分析師評級：關於tandem diabetes care你需要知道的關鍵見解
In the assessment of 12-month price targets, analysts unveil insights for Tandem Diabetes Care, presenting an average target of $57.18, a high estimate of $75.00, and a low estimate of $39.00. This upward trend is evident, with the current average reflecting a 17.49% increase from the previous average price...Tandem Diabetes Care (NASDAQ:TNDM) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Tandem Diabetes Care（納斯達克股票代碼：TNDM）在上個季度接受了11位分析師的分析，揭示了從看漲到看跌的一系列觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表簡要概述了分析師最近的評級，提供了對過去30天情緒變化的見解，並與前幾個月進行了比較以獲得整體視角。
In the assessment of 12-month price targets, analysts unveil insights for Tandem Diabetes Care, presenting an average target of $57.18, a high estimate of $75.00, and a low estimate of $39.00. This upward trend is evident, with the current average reflecting a 17.49% increase from the previous average price...
在評估12個月目標股價時，分析師公佈了對Tandem Diabetes Care的見解，將...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。